Company Filing History:
Years Active: 2015
Title: Innovations by Inventor Chen-Li Cheng
Introduction
Chen-Li Cheng is a notable inventor based in Taichung, Taiwan, recognized for his contributions to the field of pharmaceutical compositions aimed at treating urinary system disorders. With two patents to his name, Cheng has demonstrated a significant commitment to addressing health issues through innovative solutions.
Latest Patents
His latest patents include a groundbreaking method for treating urinary system disorders. This method involves a pharmaceutical composition comprising a carbon material and a water-containing carrier. The composition contains a carbon material ranging from 0.001 mg to 100 mg, designed to be instilled into the bladder to adsorb lipopolysaccharides (LPS) from bacteria. This process is intended to aid cystitis patients by discharging LPS along with urine, effectively reducing the symptoms associated with the condition.
Additionally, Cheng's pharmaceutical composition for treating urinary system disorders features a carbon material with a content exceeding 60% by weight. By ensuring that the carbon material has a diameter between 2 nm and 2 mm and a concentration of 0.1 mg/ml to 500 mg/ml per unit dose, this composition also aims to alleviate cystitis symptoms through direct contact with the bladder or related tissues.
Career Highlights
Chen-Li Cheng currently works at Feng Chia University, where he contributes to academic and industrial research endeavors. His innovative approaches have garnered attention within the medical community, particularly in the treatment of bladder-related conditions.
Collaborations
Throughout his career, Cheng has collaborated with esteemed colleagues, including Ming-Chean Hung and Sheau-Yun Yuan. These partnerships reflect a collaborative spirit in advancing research and development within the field of pharmaceuticals.
Conclusion
In summary, Chen-Li Cheng stands out as an inventor dedicated to enhancing medical treatments for urinary disorders. Through his patents and collaborative efforts, he continues to make strides in the pharmaceutical field, showcasing the vital link between innovation and healthcare solutions.